alexa The Head of Janus: Exploiting Autophagy for Cancer Therapy
ISSN: 2329-6631
Journal of Developing Drugs
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

The Head of Janus: Exploiting Autophagy for Cancer Therapy

Donat Kögel*

Experimental Neurosurgery, Department of Neurosurgery, Frankfurt University, Germany

*Corresponding Author:
Donat Koegel
Experimental Neurosurgery, Department of Neurosurgery
Goethe University Hospital, Frankfurt University, Germany
Tel: 49-69-6301-6940
Fax: 49-69-6301-5575

Received date: February 08, 2012; Accepted date: February 11, 2012; Published date: February 14, 2012

Citation: Kögel D (2012) The Head of Janus: Exploiting Autophagy for Cancer Therapy. J Develop Drugs 1:e109. doi: 10.4172/2329-6631.1000e109

Copyright: © 2012 Kögel D. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Developing Drugs

Macroautophagy (hereafter referred to as autophagy) is a complex, multi-step process normally involved in regulated turnover of longlived proteins and damaged organelles. Autophagy is a form of cellular self digestion in which cellular constituents are engulfed in doublemembrane containing autophagosomes. Their vesicular content is subsequently digested by lysosomal proteases after fusion of autophagosomes with lysosomes. In recent years, elucidation of the physiological and pathophysiological aspects of autophagy and the identification of key components of the autophagy interacting network has generated a tremendous interest in the concept of exploiting autophagy for cancer therapy [1-4].

What is the common rationale of targeting autophagy for cancer therapy? The net effects of autophagy on cell death/cell survival decisions are highly dependent of the cellular context and hence autophagy may have dual, opposing roles [5]. It is now widely accepted that autophagy primarily constitutes a quality control mechanism and a prosurvival stress response, e.g. under conditions of nutrient deprivation, organelle damage, oxidative stress or after DNA damage [6]. In line with this hypothesis, there are numerous examples and experimental paradigms where pharmacological inhibition or genetic ablation of pro-survival autophagy can sensitize cancer cells to various types of therapy [7,8]. On the other hand, there is also evidence supporting the notion that enforced over activation of autophagy can lead to “autophagic cell death” (type II cell death), i.e. massive cellular self digestion via the autophagosomal-lysosomal pathway beyond the point allowing cell survival. This could be especially relevant in apoptosis-resistant cells such as gliobastoma cells, where autophagy may act as a backup cell death mechanism executing a non-apoptotic, alternative death program [9,10].

However, this is a controversial, hotly debated issue [11,12] and the very existence of autophagic cell death has been challenged recently [13]. Indeed, in many paradigms of cell death associated with induction of autophagy, autophagy may just act as a bystander without a direct role in the death process. In line with this notion, many of the past studies on “autophagic cell death” did not really investigate the pro-death function of autophagy and therefore do not fulfil the current, more stringent criteria that recently were suggested to be applied for autophagy-dependent cell death [5,11].

Despite this ongoing controversy regarding the pro-death role of autophagy, there are a number of experimental studies suggesting that pro-autophagic drugs may elicit an autophagy-dependent cell death in certain cases [8]. In addition to these findings on drug-induced autophagic cell death in mammalian cells, there is also considerable evidence for autophagy-dependent developmental cell death in Drosophila [14,15]. Therefore, the issue of autophagy as a cell death mechanism in general and the ensuing therapeutic consequences for cancer therapy warrant further examination in order to determine whether activation of autophagy may indeed have significance for therapy, especially in apoptosis-refractory tumors.


Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Recommended Conferences

Article Usage

  • Total views: 11624
  • [From(publication date):
    February-2012 - Jul 24, 2017]
  • Breakdown by view type
  • HTML page views : 7858
  • PDF downloads :3766

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

1-702-714-7001Extn: 9037

Business & Management Journals


1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

1-702-714-7001 Extn: 9042

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version